Načítá se...
Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies
In vitro amplified human leukocyte antigen (HLA)-haploidentical donor immune cell infusion (HDICI) is not commonly used in children. Therefore, our study sought to evaluate its safety for treating childhood malignancies. Between September 2011 and September 2012, 12 patients with childhood malignanc...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sun Yat-sen University Cancer Center
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3870850/ https://ncbi.nlm.nih.gov/pubmed/23706769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.012.10298 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|